Overview
Chul Jung practices in Seoul, Republic of Korea. Jung is rated as an Advanced expert by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Their top areas of expertise are Leukemia, Acute Myeloid Leukemia (AML), Chronic Myelogenous Leukemia (CML), Bone Marrow Transplant, and Thrombectomy.
Their clinical research consists of co-authoring 153 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 6 articles in the study of Myeloproliferative Neoplasms (MPN).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloid Leukemia (AML)
- Bone Marrow Transplant
- Chronic Familial Neutropenia
- Chronic Myelogenous Leukemia (CML)
- Hepatic Venoocclusive Disease with Immunodeficiency
- LeukemiaJung isAdvanced. Learn about Leukemia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Promyelocytic Leukemia
- Adult Immune Thrombocytopenia
- AgranulocytosisJung isExperienced. Learn about Agranulocytosis.
- AnemiaJung isExperienced. Learn about Anemia.
- Aplastic AnemiaJung isExperienced. Learn about Aplastic Anemia.